Thalidomide-O-amido-C3-NH2 (TFA) manufacturers
|
| Thalidomide-O-amido-C3-NH2 (TFA) Basic information |
Product Name: | Thalidomide-O-amido-C3-NH2 (TFA) | Synonyms: | Thalidomide-O-amido-C3-NH2 (TFA);E3 Ligase Ligand-Linker Conjugates 52 (TFA);Thalidomide-O-amido-C3-NH2;Pomalidomide Related Compound 3 Triflate;N-(3-Aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide trifluoroacetic acid salt;N-(3-aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide;N-(3-aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide(TFA);N-(3-Aminopropyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate | CAS: | 2022182-58-5 | MF: | C20H21F3N4O8 | MW: | 502.4 | EINECS: | | Product Categories: | | Mol File: | 2022182-58-5.mol |  |
| Thalidomide-O-amido-C3-NH2 (TFA) Chemical Properties |
storage temp. | 2-8°C, sealed storage, away from moisture | form | Solid | color | White to off-white |
| Thalidomide-O-amido-C3-NH2 (TFA) Usage And Synthesis |
Uses | Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. | IC 50 | Cereblon | References | [1] Lohbeck J, et al. Practical synthesis of a phthalimide-based Cereblon ligand to enable PROTAC development. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5260-5262. DOI:10.1016/j.bmcl.2016.09.048 |
| Thalidomide-O-amido-C3-NH2 (TFA) Preparation Products And Raw materials |
|